IDH is a leading consumer healthcare company in the Middle East and Africa with operations in Egypt, Jordan, Sudan, Nigeria and Saudi Arabia. The Group’s core brands include Al Borg, Al Borg Scan and Al Mokhtabar in Egypt, as well as Biolab in Jordan and Saudi Arabia, Ultralab and Al Mokhtabar in Sudan and Echo Lab in Nigeria. A long track record for quality and safety has earned the company a trusted reputation, as well as internationally recognized accreditations for its portfolio of over 2,000 diagnostics tests. From its base of 538 branches as of 30 June 2022, IDH will continue to add laboratories through a Hub, Spoke and Spike business model that provides a scalable platform for efficient expansion. Beyond organic growth, the Group’s expansion plans include acquisitions in new Middle Eastern, African, and East Asian markets where its model is well-suited to capitalize on similar healthcare and consumer trends and capture a significant share of fragmented markets. IDH has been a Jersey-registered entity with a standard listing on the main market of the London Stock Exchange (ticker: IDHC) since May 2015 with a secondary listing on the EGX since May 2021 (ticker: IDHC.CA).